参考文献/References:
[1] Singh TD,Valizadeh N,Meyer FB,et al.Management and outcomes of pituitary apoplexy[J].Journal of Neurosurgery,2015,122(6):14501457.
[2] 赵 华,徐洋洋,鹿向东,等.Ki67、PTTG、VEGF与垂体腺瘤卒中的相关性研究[J].山东大学学报:医学版,2014,52(5):8285.
[3] 肖德勇,黄银兴,赵 琳,等.梗死性垂体腺瘤卒中的临床分析[J].中国微侵袭神经外科杂志,2015,20(8):344347.
[4] Chattopadhyay A,Bhansali A,Masoodi SR.Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline[J].Pituitary,2008,11(3):287292.
[5] Xu K,Yuan Y,Zhou J,et al.Pituitary adenoma apoplexy caused by rupture of an anterior communicating artery aneurysm:case report and literature review[J].World Journal of Surgical Oncology,2015,30(13):228.
[6] 郑文键,李维平,纪 涛,等.神经内镜经鼻蝶窦入路垂体腺瘤切除术的临床疗效和并发分析[J].中华神经医学杂志,2015,14(6):609613.〖JY〗(下转第1537页)〖FL)〗
[7] 钱希颖,陶维华,赵建华,等.经鼻蝶窦入路垂体腺瘤切除术的疗效及并发症的防治[J].中华神经医学杂志,2015,14(7):711714.
[8] 贾艳飞,陈群帮,赵兴利,等.神经内镜下经鼻蝶治疗垂体肿瘤的研究进展[J].中国肿瘤临床,2013,40(18):11371140.
[9] 何宝岩,高乃康.垂体瘤卒中相关性研究进展[J].内蒙古医学杂志,2017,49(9):10601061.
[10] Bujawansa S,Thondam SK,Steele C,et al.Presentation,management and outcomes in acute pituitary apoplexy:a large single center experience from the United Kingdom[J].Clin Endocrinol (Oxf),2014,80(3):419424.
[11] 金 勇,金 鑫,田沁森,等.垂体瘤卒中的研究进展[J].中风和神经疾病,2017,34(4):378379.
[12] 周 渊,王汉东,马驰原,等.显微镜下经鼻蝶入路垂体腺瘤切除术后并发症的影响因素分析[J].中国微侵袭神经外科杂志,2013,18(1):1820.
[13] Hasegawa Y,Yano S,Sakurama T,et al.Endoscopic surgical treatment for pituitary apoplexy in three elderly patients over the age of 80[J].Intracerebral Hemorrhage Research,2011,111:429433.
[14] Rajasekaran S,Vanderpump M,Baldeweg S,et al.UK guidelines for the management of pituitary apoplexy[J].Clinical Endocrinology,2011,74(1):920.
[15] Philip C,Johnston AH,Robert J,et al.Pituitary tumor apoplexy[J].Journal of Clinical Neuroscience,2015,22(6):939944.
[16] Fraser CL,Biousse V,Newman NJ,et al.Visual outcomes after treatment of pituitary adenomas[J].Neurosurg Clin N Am,2012,23(4):607619.
[17] 张晓峰,零达尚,林其炎,等.内镜下经鼻蝶入路切除垂体腺瘤临床疗效分析[J].陕西医学杂志,2018,47(6):705707.